Skip to main content
Clinical Trials/NCT03966586
NCT03966586
Completed
N/A

Syndemics and Loss from the HIV Care Continuum in India - Intervention

Brigham and Women's Hospital1 site in 1 country50 target enrollmentJune 20, 2019
ConditionsHIV Infections

Overview

Phase
N/A
Intervention
Not specified
Conditions
HIV Infections
Sponsor
Brigham and Women's Hospital
Enrollment
50
Locations
1
Primary Endpoint
Acceptability among participants and providers as assessed by semi-structured qualitative interviews
Status
Completed
Last Updated
last year

Overview

Brief Summary

The investigators will assess the feasibility and acceptability of a pilot intervention to keep people living with HIV (PLHIV) in southern India in care and virologically suppressed. The lack of understanding of the causes of loss from the HIV care continuum in India stifles the armamentarium of effective interventions to keep Indian PLHIV in care. The results of this research will demonstrate the feasibility and acceptability of a pilot intervention targeting the multiple mechanisms by which PLHIV become lost to care. By targeting these mechanisms, this intervention will be designed to be scalable in a setting where access to mental health specialists is limited.

Detailed Description

This pilot intervention represents the final Aim of the NIMH-sponsored study "Syndemics and Loss from the HIV Care Continuum in India." This trial will be conducted at the Y.R. Gaitonde Centre for AIDS Research and Education (YRG CARE), located in Chennai, the capital of Tamil Nadu state and one of the epicenters of the Indian HIV epidemic. The investigators will recruit 50 adult (age \>=18) PLHIV presenting to care at YRG CARE and ART-naïve. Participants will be recruited at their first visit to YRG CARE, at which the participant's HIV diagnosis is established or confirmed and the participant receives initial counseling and clinical care. At this recruitment stage, research assistants will conduct a pre-intervention questionnaire including measures of depressive symptoms, internalized stigma, self-efficacy, mental health, and physical health. The investigators will then randomize the patient to usual care vs. enhanced-care intervention (25 in each arm). The enhanced-care intervention will be multi-faceted, reflecting the likelihood of multiple syndemic conditions as well as evidence from LMICs suggesting that programs combining multiple approaches are the most effective in improving retention in care. The enhanced-care intervention will consist of the following components: 1. Active outreach, including bidirectional weekly SMS messaging / automated voice messaging (depending on literacy) 2. Appointments (specific appointment times/dates). 3. Financial support, including free clinic visits, labs, medications, and transportation incentives on a sliding scale based on distance to clinic 4. Microenterprise, including bag-making or food-making ventures for women 5. Enhanced counseling. Participants in the enhanced-care intervention will participate in an individual enhanced counseling program called Steps to Success, based upon a Life Steps and Problem Solving curriculum.

Registry
clinicaltrials.gov
Start Date
June 20, 2019
End Date
December 1, 2023
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Brian Chan

Associate Physician

Brigham and Women's Hospital

Eligibility Criteria

Inclusion Criteria

  • Adult PLHIV presenting to care at YRG CARE who are ART-naïve and who plan to follow-up at YRG CARE
  • Speaks Tamil, Telugu, or English

Exclusion Criteria

  • Previous ART exposure
  • Not competent to provide informed consent or participate in the study

Outcomes

Primary Outcomes

Acceptability among participants and providers as assessed by semi-structured qualitative interviews

Time Frame: 12 months

Acceptability among patients and providers as measured by semi-structured qualitative interviews of participants and providers

Feasibility as assessed by semi-structured qualitative interviews

Time Frame: 12 months

Minimal negative impact on clinical work flow and ability to deliver all intervention components, particularly all sessions of enhanced counseling, as measured by semi-structured qualitative interviews of providers

Secondary Outcomes

  • Depressive symptoms as measured by PHQ-9(12 months)
  • Viral suppression (Undetectable HIV-1 RNA, <50 copies / mL)(3 months)
  • ART initiation success (accepted ART and continued ART for at least 6 months)(6 months)
  • Food insecurity as measured by Household Food Insecurity Access Scale(12 months)
  • Retention in care(12 months)
  • Internalized stigma as measured by Internalized AIDS-Related Stigma Scale(12 months)
  • Self-efficacy as measured by General Self-Efficacy Scale--shortened version(12 months)
  • Social support as measured by Multidimensional Scale of Perceived Social Support(12 months)

Study Sites (1)

Loading locations...

Similar Trials